TITLE

Letter: Cerebral embolism and oral contraceptives

AUTHOR(S)
Bickerstaff, E R
PUB. DATE
December 1973
SOURCE
British Medical Journal;12/22/1973, Vol. 4 Issue 5894, p736
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64109221

 

Related Articles

  • Chronic meningitis: still a diagnostic challenge. Hildebrand, J.; Aoun, M. // Journal of Neurology;Jun2003, Vol. 250 Issue 6, p653 

    Chronic meningitis is characterized by a progressive, subacute onset of lepomeningeal disease and persisting cerebrospinal fluid (CSF) abnormalities such as elevated protein level and pleocytosis for at least one month. The array of aetiologies is very wide comprising non-infectious...

  • Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. Lidegaard, Ojvind // BMJ: British Medical Journal (International Edition);4/10/93, Vol. 306 Issue 6883, p956 

    Examines the risk of cerebral thromboembolism in women using low dose oral contraception in Denmark. Association of oral contraceptives with cerebral thromboembolic attacks; Comparison of risks between estrogen and progestogen pills; Effect of age on cerebral thromboembolic attack.

  • Cerebral metastasis proven 1 year after an embolic cerebral infarct from pleuropulmonary blastoma. Tan Kendrick, Anne // Pediatric Radiology;Mar2004, Vol. 34 Issue 3, p283 

    Presents letters to the editor about cerebral metastasis after an embolic cerebral infarct from pleuropulmonary blastoma.

  • Prothrombotic Activity of Oral Contraceptives in Patients with Congenital Thrombophilia. Aznar, Justo; Mira, Yolanda // Clinical & Applied Thrombosis/Hemostasis;Jan2002, Vol. 8 Issue 1, p91 

    Presents a letter to the editor on the prothrombotic activity of oral contraceptives in patients with congenital thrombophilia.

  • Evaluation of a Unique Oral Contraceptive in the Treatment of Premenstrual Dysphoric Disorder. Megivern, Deborah // Journal of Women's Health & Gender-Based Medicine;Mar2002, Vol. 11 Issue 2, p95 

    Presents a letter to the editor about the oral contraceptive in the treatment of premenstrual dysphoric disorder.

  • Risk of Chlamydial PID and Oral Contraceptives. Washington, A. Eugene; Padian, Nancy S.; Hearst, Norman; Schachter, Julius // JAMA: Journal of the American Medical Association;10/24/90-10/31/90, Vol. 264 Issue 16, p2072 

    Presents a letter to the editor on the risk of chlamydial pelvic inflammatory disease and oral contraceptives.

  • Risk of Chlamydial PID and Oral Contraceptives. Job-Spira, N.; Fernandez, H.; Coste, J.; Papiernik, E.; Spira, A. // JAMA: Journal of the American Medical Association;10/24/90-10/31/90, Vol. 264 Issue 16, p2073 

    Presents a letter to the editor on the risk of chlamydial pelvic inflammatory disease and oral contraceptives.

  • UPDATE ON LEVONORGESTREL FOR EMERGENCY CONTRACEPTION. Strayer, Scott M.; Couchenour, Rachel L. // Journal of Family Practice;Dec1999, Vol. 48 Issue 12, p1002 

    A letter to the editor is presented in response to the article "Combined Oral Contraceptives Versus Levonorgestrel for Emergency Contraception."

  • Ethinylestradiol.  // Reactions Weekly;2/6/2010, Issue 1287, p20 

    The article describes the case of a man who developed pulmonary embolism and Budd-Chiari syndrome (BCS) during oral contraception with ethinylestradiol.

  • Pulmonary embolism: case report.  // Reactions Weekly;10/29/2005, Issue 1075, p10 

    Presents a case report about pulmonary embolism. Effect of the oral contraceptive ethinylestradiol/norgestimate and valdecoxib drug on a woman; Significance of warfarin to the woman.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics